From the web: “Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer’s and Parkinson’s research”

With every passing day, it becomes clearer who’s reaping the benefit of the huge tax cut handed over to American corporations by the Republican-dominated Congress in December. Spoiler alert: Not workers or customers, but shareholders, especially the rich ones.

from Pocket http://ift.tt/2CKddVX
via IFTTT

Advertisements